20th July 2018, The Royal Society, London, UK
|09:00–09:40||Welcome - Prediction and prevention of type 1 diabetes in children||Francesco Chiarelli|
|09:40–10:40||Practical insulin treatment||Peter Hindmarsh|
|11:00–12:30||Advances in technology for diabetes treatment||Peter Hindmarsh|
|13:30–14:10||Diabetic ketoacidosis||John Gregory|
|15:05–15:45||Chronic complications||Francesco Chiarelli|
|15:45–16:00||Closing remarks||Francesco Chiarelli|
Following this meeting, delegates will be able to:
- Estimate the risk of, and understand how to predict and possibly prevent, type 1 diabetes in children and adolescents
- Assess the risks of, and effectively manage, acute and chronic complications of type 1 diabetes
- Discuss the best treatment options, including new insulins and advanced technologies, for maintaining optimal glucose control
This activity has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 5 category 1 (external) CPD credit(s).
RCPCH has approved this activity for CPD in accordance with the current RCPCH CPD Guidelines.
The Royal Society 6-9 Carlton House Terrace, London, SW1Y 5AG
Nearest stations: Charing Cross (Bakerloo & Northern lines) and Piccadilly Circus (Bakerloo and Piccadilly lines)
FacultyFrancesco Chiarelli - Programme Director
Professor and Head of Paediatrics
University of Chieti, Italy
Professor Chiarelli is on the Editorial Board of Journal of Pediatric Endocrinology and Metabolism, Pediatric Diabetes, Hormone Research, Diabetes, Nutrition and Metabolism. He is a member of several professional organizations, including the European Society of Paediatric Endocrinology (ESPE), the International Society for Pediatric and Adolescent Diabetes (ISPAD) (Member of the Advisory Council 1990-1993, Chair of Scientific Committee 2001-2004), the American Diabetes Association (ADA), the International Pediatric Association (IPA), the Italian Society for Pediatric Endocrinology and Diabetology (ISPED)(Member of the Advisory Council 1990-1996).
Professor Chiarelli as ESPE Secretary General (2004-2011) and ESPE President (2008-2009 and 2012-2013). He was President of the Italian Society for Paediatric Research (ISPR)(2012-2015) and Member of the WHO Task Force for Childhood Diabetes. He is currently a Consultant of the European Commission and of the WHO for Non-Communicable Diseases (NCD) in Children.
Professor of Paediatric Endocrinology and Divisional Clinical Director for Paediatrics, Adolescents and Young People
University College London, UK
Professor in Paediatric Endocrinology
Cardiff University, UK
Professor Gregory has a longstanding interest in training in Paediatric Endocrinology and on behalf of the European Society for Paediatric Endocrinology (ESPE) in the past has led the Paediatric Endocrine Training Centres for Africa in Nairobi and Lagos. He now leads the annual ESPE Winter School targeting trainees in Eastern Europe. He is Principal Regional Examiner for the Middle-East for the MRCPCH exam for The Royal College of Paediatric sand Child Health. He has published over 100 papers in peer-reviewed journals and is co-author of Practical Endocrinology and Diabetes in Children, now being revised for its fourth edition.
Consultant in Paediatric Diabetes and Endocrinology and Clinical Lead in Paediatric Diabetes
John Radcliffe Hospital, Oxford, UK
Dr Besser moved to Exeter in 2009-2012 to train with Professor Andrew Hattersley, at the Peninsula Medical School, gaining a PhD in the use of urinary C-peptide as a non-invasive measure of endogenous insulin secretion, funded by Diabetes UK. She is a paediatrician, and a researcher at the Oxford NIHR Biomedical Research Centre and is interested in the natural history of type 1 diabetes, interventions to preserve C-peptide, and identification of non-type 1 diabetes in childhood.
This programme is made possible thanks to an independent educational grant from Novo Nordisk A/S.
Phone +44 (0) 203 192 2023
Springer Healthcare IME
4 Crinan Street
London, N1 9XW, UK